Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-029053

Chief Medical Officer sold 17,500 shares at an average $22.85 ($399,901)

  • Chief Medical Officer acquired 7,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-08 Exercise or conversion : show line 1 in the form +2,613 $5.28 $13,797 2,613 D
2019-05-08 Sale : show line 2 in the form −2,613 $23.50 $61,406 0 D
2019-05-08 Sale : show line 3 in the form −3,162 $23.51 $74,339 110,332 I
2019-05-09 Exercise or conversion : show line 4 in the form +2,653 $5.28 $14,008 2,653 D
2019-05-09 Sale : show line 5 in the form −2,453 $22.86 $56,076 200 D
2019-05-09 Sale : show line 6 in the form −200 $23.58 $4,716 0 D
2019-05-09 Sale : show line 7 in the form −3,010 $22.83 $68,718 107,322 I
2019-05-09 Sale : show line 8 in the form −200 $23.60 $4,720 107,122 I
Open-market sales · 17,500 sh · avg $22.85 · $399,901

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2019-05-08 Exercise or conversion : show line 12 in the form Stock Option (right to buy) −2,613 91,138 D
2019-05-09 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −2,653 88,485 D
2019-05-10 Exercise or conversion : show line 14 in the form Stock Option (right to buy) −2,546 85,939 D
Loading xslF345X03/doc4.xml…